About this trial

The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.

Eligibility criteria

Qualifiers

Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease

Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)

One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)

Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue

Disqualifiers

Unable to provide informed consent for participation for one's self or by legally authorized representative/legal guardian/parent

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
Duke University27710, DurhamNorth Carolina, United States

Sponsors and collaborators

Duke University

Lead sponsor